Salivary gland atrophy in Sprintec - how severe and when it was recovered? (a real world drug study)
Summary:
There is no report of severity or recovery of Salivary gland atrophy by people who take Sprintec yet.
What is Sprintec?
Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.
What is Salivary Gland Atrophy?
Salivary gland atrophy (wasting of salivary gland) is found to be associated with 4 drugs and 42 conditions by eHealthMe. Check the latest studies of Salivary gland atrophy.
No report is found.
Do you take Sprintec and have Salivary gland atrophy?
Check whether Salivary gland atrophy is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on ethinyl estradiol; norgestimate (the active ingredients of Sprintec). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin D and Tegretol drug interactions for women aged 60+ - 4 seconds ago
- Osteitis and drugs of ingredients of calcium - 5 seconds ago
- Could Ibu cause Arthritis? - 7 seconds ago
- Hydroxyzine Pamoate and Bone And Joint Pain for Women aged 30-39 - 8 seconds ago
- Hydroxyzine Pamoate and Joint Aches for Women aged 30-39 - 9 seconds ago
- Hydroxyzine Pamoate and Stiffness In A Joint for Women aged 30-39 - 9 seconds ago
- Hydroxyzine Pamoate and Pain - Joints for Women aged 30-39 - 9 seconds ago
- Could Vasotec cause Cerebellar Atrophy? - 9 seconds ago
- Hydroxyzine Pamoate and Arthralgia for Women aged 30-39 - 10 seconds ago
- Hydroxyzine Pamoate and Joint Pain for Women aged 30-39 - 10 seconds ago